Guangzhou Jet Bio-Filtration Co (688026) Fair Value & Analysis
Healthcare · CN · Market cap 1.9B CNY
Fair value as of: Jun 24, 2026
Analysis
Guangzhou Jet Bio-Filtration Co (688026) currently trades at ¥16.00, while our model-based Fair Value estimate is ¥7.56 — implying the stock looks roughly 52.8% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Guangzhou Jet Bio-Filtration Co., Ltd. researches, develops, manufactures, and sells biological laboratory consumable products. Its products include bioprocess, biological culture, liquid handling and storage, filtration products, molecular biology, cellsafe, medical consumables, biological reagents, laboratory equipment, petri dishes, ELISA plates, immuno micro plates, inoculating loops and needles, cuvettes, latex powder-free gloves, NBR gloves, and other products. The company was founded in 2001 and is headquartered in Guangzhou, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Guangzhou Jet Bio-Filtration Co (688026) undervalued?
What is the fair value of 688026?
What is the quality score of 688026?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.